Panelists: Malcolm R. Bell, Matthew Budoff, Ravi Dave Case presentation TBD Yes, here is the evidence! Matthew Budoff, MD Only if FFR is incorporated (FFR CT) John Messenger, MD Q&A
Panelists: Stefan Bertog, Morton J. Kern, Poonam Velagapudi FFR-GUIDED DECISION MAKING TO DEFER PCI Case presentation Giora Weisz, MD The evidence is overwhelming! Just do it! Morton Kern, MD... Read More
Panelists: Joseph Aragon, Joaquin Cigarroa, Vinod Prasad Case introduction: 2 patients with 3 vessel cads: how would you treat? Louai Razzouk, MD Here is what I would do. Here is... Read More
Panelists: Ravi Dave, Neil Kleiman, Jonathan Tobis DEBATE: INTRAVASCULAR CORONARY IMAGING – GUIDED PCI SHOULD BECOME A CLASS IA INDICATION Yes…the evidence is overwhelming! Bassem Chehab, MD No…not yet!... Read More
Panelists: Joseph Aragon, Joaquin Cigarroa, Pranav Patel DEBATE: ARE TICAGRELOR BENEFITS IN ACS SUFFICIENT TO COUNTER BLEEDING RISKS AND COST Yes…here is why! Joseph Aragon, MD No…here is why!... Read More
Panelists: Suhail Dohad, Navin Kapur, Neil Kleiman Impella supported PCI in complex patients: the PROTECT 4 trial and beyond Gregg W. Stone, MD (Virtual) Q&A Advanced skills in alternative... Read More
Panelists: Ravi Dave, John Messenger, Pranav Patel The Penumbra CAT Rx really works! Case Studies Naveed Adoni, MD The impact of thrombus burden classification on trial design: it is all... Read More
Panelists: Suhail Dohad, Nadia Sutton, Mike Wayman CTO REVASCULARIZATION CAN BE SAFER Only CTO operators should perform CTOs Mike Wayman, MD CTOs can be safely performed by any... Read More
Panelists: Vinod Prasad, Stefan Kiesz, Ramzan M. Zakir INTRAVASCULAR LITHOTRIPSY IS A DISRUPTIVE TECHNOLOGY…. CASES FROM AROUND THE US Undilatable lesions: ISR, ACS, etc.. Sanjay Mehta, MD Calcified Left main... Read More
Panelists: Rajiv Jauhar, Navin Kapur, Tim A. Fischell ROLE OF RENAL ARTERY DENERVATION Renal denervation should become the primary modality to treat resistant HTN: here is the evidence... Read More
RECEPTION WELCOME AND INTRODUCTION Moderators: Suhail Dohad, Amir Kaki Panelists: TBD Catheter-based pulmonary artery thrombectomy: Where do stand in 2023 Suhail Dohad, MD Q&A The FLASH thrombectomy catheter:... Read More
Panelists: Aziz Ghaly, Ray Matthews, Firas Zahr DEBATE: TAVR-EMBOLIC PROTECTION DEVICES Case presentation John Messenger, MD The PROTECTED TAVR trial did not meet its primary endpoint, But the Sentinel... Read More
TAVR DURABILITY, FAILURE MODES, AND TREATMENT OPTIONS Case presentation: Bilateral Basilica of Failed TAVR Chad Kliger, MD What we know, and don’t know, about TAVR durability Raj Makkar, MD... Read More
Panelists: Bassem Chehab, Maurice Buchbinder, Gagan Singh TRANSCATHETER MITRAL VALVE REPAIR: TAILORING DEVICE/TECHNIQUE TO ANATOMY Case presentation: severe A2 prolapse/flail: 1 or 2 clips? Marcella Calfon Press, MD... Read More
MITRA VALVE REPLACEMENT : TECHNOLOGY PIPELINE AND CASE STUDIES Tendyne in FMR, DMR and MAC: case studies Raj Makkar, MD Intrepid in FMR, DMR and MAC: case studies Firas Zahr,... Read More
Panelists: Gagan Singh, Ruby Satpathy, Firas Zahr The TRILUMINATE Trial: Does the TriClip worth the cost and effort? Gagan Singh, MD Q&A DEBATE: INTRA-PROCEDURE IMAGING FOR TRANSCATHETER TRICUSPID VALVE... Read More
Panelists: Stefan Bertog, Maurice Buchbinder, Gagan Singh Is Pre-Procedure imaging really needed? Why? What modality? Moody Makar, MD Q&A ICE guided LAAO closure without anaesthesia – The default strategy! Here... Read More
Panelists: Zahid Amin, Steve Goldberg, Jonathan M, Tobis PFO closure: complex case studies: tailoring the device/technique to the defect Zahid Amin, MD Q&A ASD closure (including sinus venosus): complex case... Read More
Moderators: Stefan Bertog, Antonio Frangieh, Marcella Calfon Press LAA closure of a remnant LAA after surgical AtriClip Ashok Chaudhary, MD Q&A Pre-existing patient prosthetic mismatch in TAVR. What... Read More